Coherus BioSciences Inc. (CHRS)
Coherus BioSciences Max Pain By Strike
CHRS trades at $1.11, 122.0% above the near-term max pain of $0.5 expiring Sep 19, 2025 (29 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is stable across expirations ($0.5-$0.5), indicating stable market expectations. Key magnetic zone at 1 where 5 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Coherus BioSciences Max Pain By Expiry
Max pain for CHRS shows stable levels around 0.50, reflecting balanced market expectations. The 0% spread suggests strong consensus on fair value. Most levels below 1.11 may cap rallies. Strong magnetic level at 1 (5 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 0.5 | -0.61 (-54.95%) |
| Oct 17, 2025 | 0.5 | -0.61 (-54.95%) |
| Nov 21, 2025 | 0.5 | -0.61 (-54.95%) |
| Jan 16, 2026 | 0.5 | -0.61 (-54.95%) |
| Feb 20, 2026 | 0.5 | -0.61 (-54.95%) |